HEADER TRANSFERASE 18-JAN-19 6NPV TITLE C-ABL KINASE DOMAIN WITH THE ACTIVATOR(CMPD51), N-(1-(3,4- TITLE 2 DICHLOROPHENYL)-4-(2-HYDROXYETHYL)-4,5-DIHYDRO-1H-PYRAZOL-3-YL) TITLE 3 ISONICOTINAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA AFF. FRUGIPERDA 2 RZ-2014; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1491790 KEYWDS ACTIVATOR, KINASE, ALLOSTERIC, SIGNALING PROTEIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.CAMPOBASSO REVDAT 2 13-MAR-24 6NPV 1 HETSYN REVDAT 1 13-MAR-19 6NPV 0 JRNL AUTH G.L.SIMPSON,S.M.BERTRAND,J.A.BORTHWICK,N.CAMPOBASSO, JRNL AUTH 2 J.CHABANET,S.CHEN,J.COGGINS,J.COTTOM,S.B.CHRISTENSEN, JRNL AUTH 3 H.C.DAWSON,H.L.EVANS,A.N.HOBBS,X.HONG,B.MANGATT, JRNL AUTH 4 J.MUNOZ-MURIEDAS,A.OLIFF,D.QIN,P.SCOTT-STEVENS,P.WARD, JRNL AUTH 5 Y.WASHIO,J.YANG,R.J.YOUNG JRNL TITL IDENTIFICATION AND OPTIMIZATION OF NOVEL SMALL C-ABL KINASE JRNL TITL 2 ACTIVATORS USING FRAGMENT AND HTS METHODOLOGIES. JRNL REF J. MED. CHEM. V. 62 2154 2019 JRNL REFN ISSN 1520-4804 JRNL PMID 30689376 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01872 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.YANG,N.CAMPOBASSO,M.P.BIJU,K.FISHER,X.Q.PAN,J.COTTOM, REMARK 1 AUTH 2 S.GALBRAITH,T.HO,H.ZHANG,X.HONG,P.WARD,G.HOFMANN, REMARK 1 AUTH 3 B.SIEGFRIED,F.ZAPPACOSTA,Y.WASHIO,P.CAO,J.QU,S.BERTRAND, REMARK 1 AUTH 4 D.Y.WANG,M.S.HEAD,H.LI,S.MOORES,Z.LAI,K.JOHANSON,G.BURTON, REMARK 1 AUTH 5 C.ERICKSON-MILLER,G.SIMPSON,P.TUMMINO,R.A.COPELAND,A.OLIFF REMARK 1 TITL DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE, REMARK 1 TITL 2 SMALL-MOLECULE C-ABL KINASE ACTIVATOR THAT BINDS TO THE REMARK 1 TITL 3 MYRISTOYL BINDING SITE. REMARK 1 REF CHEM. BIOL. V. 18 177 2011 REMARK 1 REFN ISSN 1879-1301 REMARK 1 DOI 10.1016/J.CHEMBIOL.2010.12.013 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.72 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 70102 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 3496 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.7301 - 5.4305 0.99 2844 158 0.1887 0.2094 REMARK 3 2 5.4305 - 4.3114 0.99 2742 142 0.1635 0.1830 REMARK 3 3 4.3114 - 3.7667 1.00 2694 156 0.1582 0.1922 REMARK 3 4 3.7667 - 3.4224 1.00 2703 115 0.1687 0.1993 REMARK 3 5 3.4224 - 3.1772 0.99 2680 143 0.1841 0.1895 REMARK 3 6 3.1772 - 2.9899 1.00 2660 149 0.1810 0.1976 REMARK 3 7 2.9899 - 2.8402 1.00 2677 148 0.1890 0.2553 REMARK 3 8 2.8402 - 2.7166 1.00 2671 129 0.1853 0.1843 REMARK 3 9 2.7166 - 2.6120 1.00 2644 147 0.1862 0.2402 REMARK 3 10 2.6120 - 2.5219 1.00 2648 143 0.1844 0.2285 REMARK 3 11 2.5219 - 2.4430 1.00 2675 127 0.1891 0.2021 REMARK 3 12 2.4430 - 2.3732 1.00 2632 142 0.1824 0.2020 REMARK 3 13 2.3732 - 2.3107 1.00 2677 127 0.1801 0.1889 REMARK 3 14 2.3107 - 2.2544 1.00 2633 146 0.1772 0.2068 REMARK 3 15 2.2544 - 2.2031 1.00 2624 139 0.1788 0.1898 REMARK 3 16 2.2031 - 2.1562 1.00 2676 129 0.1778 0.1845 REMARK 3 17 2.1562 - 2.1131 1.00 2652 143 0.1795 0.1978 REMARK 3 18 2.1131 - 2.0732 1.00 2622 157 0.1775 0.1784 REMARK 3 19 2.0732 - 2.0362 1.00 2643 130 0.1876 0.2109 REMARK 3 20 2.0362 - 2.0017 1.00 2646 147 0.1885 0.2451 REMARK 3 21 2.0017 - 1.9694 1.00 2606 134 0.2065 0.2159 REMARK 3 22 1.9694 - 1.9391 1.00 2659 141 0.2105 0.2462 REMARK 3 23 1.9391 - 1.9106 1.00 2622 140 0.2279 0.2453 REMARK 3 24 1.9106 - 1.8837 1.00 2660 125 0.2382 0.2836 REMARK 3 25 1.8837 - 1.8600 1.00 2616 139 0.2597 0.3103 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.330 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.01 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4530 REMARK 3 ANGLE : 0.930 6120 REMARK 3 CHIRALITY : 0.054 629 REMARK 3 PLANARITY : 0.005 773 REMARK 3 DIHEDRAL : 10.300 3171 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NPV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000239188. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-AUG-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9787 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70192 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 74.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.77400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 - 3 % PEG 400 0.1 HEPES PH 7.5 2M REMARK 280 AMSO4, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.48650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.68050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.64350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.68050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.48650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.64350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 234 REMARK 465 HIS A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 465 HIS A 240 REMARK 465 GLU A 241 REMARK 465 ASN A 242 REMARK 465 LEU A 243 REMARK 465 TYR A 244 REMARK 465 PHE A 245 REMARK 465 GLN A 246 REMARK 465 GLY A 247 REMARK 465 SER A 248 REMARK 465 PRO A 249 REMARK 465 ASN A 250 REMARK 465 GLU A 294 REMARK 465 ASP A 295 REMARK 465 THR A 296 REMARK 465 MET A 297 REMARK 465 GLU A 298 REMARK 465 SER A 520 REMARK 465 ILE A 521 REMARK 465 SER A 522 REMARK 465 ASP A 523 REMARK 465 GLU A 524 REMARK 465 VAL A 525 REMARK 465 GLU A 526 REMARK 465 LYS A 527 REMARK 465 GLU A 528 REMARK 465 LEU A 529 REMARK 465 GLY A 530 REMARK 465 LYS A 531 REMARK 465 MET B 234 REMARK 465 HIS B 235 REMARK 465 HIS B 236 REMARK 465 HIS B 237 REMARK 465 HIS B 238 REMARK 465 HIS B 239 REMARK 465 HIS B 240 REMARK 465 GLU B 241 REMARK 465 ASN B 242 REMARK 465 LEU B 243 REMARK 465 TYR B 244 REMARK 465 PHE B 245 REMARK 465 GLN B 246 REMARK 465 GLY B 247 REMARK 465 SER B 248 REMARK 465 PRO B 249 REMARK 465 ASN B 250 REMARK 465 TYR B 251 REMARK 465 LYS B 293 REMARK 465 GLU B 294 REMARK 465 ASP B 295 REMARK 465 THR B 296 REMARK 465 MET B 297 REMARK 465 GLU B 298 REMARK 465 LEU B 403 REMARK 465 SER B 404 REMARK 465 ARG B 405 REMARK 465 LEU B 406 REMARK 465 MET B 407 REMARK 465 THR B 408 REMARK 465 GLY B 409 REMARK 465 ASP B 410 REMARK 465 THR B 411 REMARK 465 TYR B 412 REMARK 465 THR B 413 REMARK 465 ALA B 414 REMARK 465 HIS B 415 REMARK 465 ALA B 416 REMARK 465 GLY B 417 REMARK 465 GLY B 530 REMARK 465 LYS B 531 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 251 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 258 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 326 CD NE CZ NH1 NH2 REMARK 470 THR A 408 OG1 CG2 REMARK 470 ASP A 410 CG OD1 OD2 REMARK 470 LYS A 434 CD CE NZ REMARK 470 GLU B 327 CG CD OE1 OE2 REMARK 470 LYS B 375 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG B 258 O PRO B 329 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 252 -160.20 -103.62 REMARK 500 LYS A 264 -142.76 -109.12 REMARK 500 ARG A 381 -10.34 88.55 REMARK 500 ASP A 382 48.40 -150.65 REMARK 500 TYR A 459 54.75 39.00 REMARK 500 LYS B 264 -142.26 -106.85 REMARK 500 ARG B 381 -8.39 84.26 REMARK 500 ASP B 382 47.05 -148.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue STI A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KWP A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue STI B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2PE B 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KWP B 607 DBREF 6NPV A 248 531 UNP P00519 ABL1_HUMAN 229 512 DBREF 6NPV B 248 531 UNP P00519 ABL1_HUMAN 229 512 SEQADV 6NPV MET A 234 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS A 235 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS A 236 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS A 237 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS A 238 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS A 239 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS A 240 UNP P00519 EXPRESSION TAG SEQADV 6NPV GLU A 241 UNP P00519 EXPRESSION TAG SEQADV 6NPV ASN A 242 UNP P00519 EXPRESSION TAG SEQADV 6NPV LEU A 243 UNP P00519 EXPRESSION TAG SEQADV 6NPV TYR A 244 UNP P00519 EXPRESSION TAG SEQADV 6NPV PHE A 245 UNP P00519 EXPRESSION TAG SEQADV 6NPV GLN A 246 UNP P00519 EXPRESSION TAG SEQADV 6NPV GLY A 247 UNP P00519 EXPRESSION TAG SEQADV 6NPV MET B 234 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS B 235 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS B 236 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS B 237 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS B 238 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS B 239 UNP P00519 EXPRESSION TAG SEQADV 6NPV HIS B 240 UNP P00519 EXPRESSION TAG SEQADV 6NPV GLU B 241 UNP P00519 EXPRESSION TAG SEQADV 6NPV ASN B 242 UNP P00519 EXPRESSION TAG SEQADV 6NPV LEU B 243 UNP P00519 EXPRESSION TAG SEQADV 6NPV TYR B 244 UNP P00519 EXPRESSION TAG SEQADV 6NPV PHE B 245 UNP P00519 EXPRESSION TAG SEQADV 6NPV GLN B 246 UNP P00519 EXPRESSION TAG SEQADV 6NPV GLY B 247 UNP P00519 EXPRESSION TAG SEQRES 1 A 298 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SEQRES 2 A 298 GLY SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR SEQRES 3 A 298 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR SEQRES 4 A 298 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU SEQRES 5 A 298 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU SEQRES 6 A 298 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU SEQRES 7 A 298 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS SEQRES 8 A 298 THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET SEQRES 9 A 298 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN SEQRES 10 A 298 ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA SEQRES 11 A 298 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS SEQRES 12 A 298 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU SEQRES 13 A 298 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY SEQRES 14 A 298 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS SEQRES 15 A 298 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 16 A 298 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL SEQRES 17 A 298 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR SEQRES 18 A 298 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL SEQRES 19 A 298 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO SEQRES 20 A 298 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA SEQRES 21 A 298 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA SEQRES 22 A 298 GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SEQRES 23 A 298 SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS SEQRES 1 B 298 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SEQRES 2 B 298 GLY SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR SEQRES 3 B 298 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR SEQRES 4 B 298 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU SEQRES 5 B 298 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU SEQRES 6 B 298 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU SEQRES 7 B 298 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS SEQRES 8 B 298 THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET SEQRES 9 B 298 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN SEQRES 10 B 298 ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA SEQRES 11 B 298 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS SEQRES 12 B 298 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU SEQRES 13 B 298 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY SEQRES 14 B 298 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS SEQRES 15 B 298 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 16 B 298 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL SEQRES 17 B 298 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR SEQRES 18 B 298 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL SEQRES 19 B 298 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO SEQRES 20 B 298 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA SEQRES 21 B 298 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA SEQRES 22 B 298 GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SEQRES 23 B 298 SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS HET SO4 A 601 5 HET STI A 602 37 HET KWP A 603 25 HET SO4 B 601 5 HET SO4 B 602 5 HET STI B 603 37 HET GOL B 604 6 HET GOL B 605 6 HET 2PE B 606 28 HET KWP B 607 25 HETNAM SO4 SULFATE ION HETNAM STI 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4- HETNAM 2 STI PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE HETNAM KWP ~{N}-[(4~{S})-2-(3,4-DICHLOROPHENYL)-4-(2- HETNAM 2 KWP HYDROXYETHYL)-3,4-DIHYDROPYRAZOL-5-YL]PYRIDINE-4- HETNAM 3 KWP CARBOXAMIDE HETNAM GOL GLYCEROL HETNAM 2PE NONAETHYLENE GLYCOL HETSYN STI STI-571; IMATINIB HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 SO4 3(O4 S 2-) FORMUL 4 STI 2(C29 H31 N7 O) FORMUL 5 KWP 2(C17 H16 CL2 N4 O2) FORMUL 9 GOL 2(C3 H8 O3) FORMUL 11 2PE C18 H38 O10 FORMUL 13 HOH *261(H2 O) HELIX 1 AA1 GLU A 257 THR A 259 5 3 HELIX 2 AA2 GLY A 268 GLN A 271 5 4 HELIX 3 AA3 LYS A 282 SER A 284 5 3 HELIX 4 AA4 GLU A 300 GLU A 311 1 12 HELIX 5 AA5 ASN A 341 CYS A 349 1 9 HELIX 6 AA6 ASN A 355 LYS A 376 1 22 HELIX 7 AA7 ALA A 384 ARG A 386 5 3 HELIX 8 AA8 GLU A 392 HIS A 394 5 3 HELIX 9 AA9 GLY A 402 LEU A 406 5 5 HELIX 10 AB1 PRO A 421 THR A 425 5 5 HELIX 11 AB2 ALA A 426 ASN A 433 1 8 HELIX 12 AB3 SER A 436 THR A 453 1 18 HELIX 13 AB4 ASP A 463 SER A 465 5 3 HELIX 14 AB5 GLN A 466 LYS A 473 1 8 HELIX 15 AB6 PRO A 484 TRP A 495 1 12 HELIX 16 AB7 ASN A 498 ARG A 502 5 5 HELIX 17 AB8 SER A 504 SER A 519 1 16 HELIX 18 AB9 GLU B 257 THR B 259 5 3 HELIX 19 AC1 GLY B 268 GLN B 271 5 4 HELIX 20 AC2 LYS B 282 SER B 284 5 3 HELIX 21 AC3 GLU B 300 LYS B 310 1 11 HELIX 22 AC4 ASN B 341 CYS B 349 1 9 HELIX 23 AC5 ASN B 355 LYS B 376 1 22 HELIX 24 AC6 ALA B 384 ARG B 386 5 3 HELIX 25 AC7 GLU B 392 HIS B 394 5 3 HELIX 26 AC8 PRO B 421 THR B 425 5 5 HELIX 27 AC9 ALA B 426 ASN B 433 1 8 HELIX 28 AD1 SER B 436 THR B 453 1 18 HELIX 29 AD2 ASP B 463 SER B 465 5 3 HELIX 30 AD3 GLN B 466 LYS B 473 1 8 HELIX 31 AD4 PRO B 484 TRP B 495 1 12 HELIX 32 AD5 ASN B 498 ARG B 502 5 5 HELIX 33 AD6 SER B 504 LEU B 529 1 26 SHEET 1 AA1 5 ILE A 261 LYS A 266 0 SHEET 2 AA1 5 VAL A 275 TRP A 280 -1 O GLU A 277 N HIS A 265 SHEET 3 AA1 5 LEU A 285 THR A 291 -1 O LEU A 285 N TRP A 280 SHEET 4 AA1 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290 SHEET 5 AA1 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333 SHEET 1 AA2 2 CYS A 388 VAL A 390 0 SHEET 2 AA2 2 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389 SHEET 1 AA3 2 THR A 413 HIS A 415 0 SHEET 2 AA3 2 ALA A 418 PHE A 420 -1 O PHE A 420 N THR A 413 SHEET 1 AA4 5 ILE B 261 LYS B 266 0 SHEET 2 AA4 5 VAL B 275 TRP B 280 -1 O VAL B 279 N THR B 262 SHEET 3 AA4 5 LEU B 285 LEU B 292 -1 O LEU B 285 N TRP B 280 SHEET 4 AA4 5 PHE B 330 GLU B 335 -1 O ILE B 332 N LYS B 290 SHEET 5 AA4 5 LEU B 320 CYS B 324 -1 N LEU B 321 O ILE B 333 SHEET 1 AA5 2 CYS B 388 VAL B 390 0 SHEET 2 AA5 2 VAL B 396 VAL B 398 -1 O LYS B 397 N LEU B 389 CISPEP 1 PRO A 328 PRO A 329 0 -0.52 CISPEP 2 PRO B 328 PRO B 329 0 -5.15 SITE 1 AC1 4 ARG A 492 GLN A 496 HOH A 707 HOH A 812 SITE 1 AC2 15 LEU A 267 ALA A 288 LYS A 290 GLU A 305 SITE 2 AC2 15 MET A 309 ILE A 312 VAL A 318 THR A 334 SITE 3 AC2 15 MET A 337 ILE A 379 HIS A 380 ALA A 399 SITE 4 AC2 15 ASP A 400 PHE A 401 HOH A 781 SITE 1 AC3 10 ARG A 351 ALA A 356 ALA A 363 LEU A 448 SITE 2 AC3 10 ILE A 451 ALA A 452 TYR A 454 GLU A 481 SITE 3 AC3 10 GLY A 482 PRO A 484 SITE 1 AC4 4 ARG A 326 ARG A 479 GLU A 481 GLY A 482 SITE 1 AC5 2 LYS A 473 LYS B 313 SITE 1 AC6 16 LEU B 267 ALA B 288 LYS B 290 GLU B 305 SITE 2 AC6 16 MET B 309 ILE B 312 VAL B 318 THR B 334 SITE 3 AC6 16 PHE B 336 MET B 337 ILE B 379 HIS B 380 SITE 4 AC6 16 ALA B 399 ASP B 400 PHE B 401 HOH B 786 SITE 1 AC7 5 ASP B 474 ARG B 476 ARG B 492 TRP B 495 SITE 2 AC7 5 HOH B 764 SITE 1 AC8 8 LYS B 313 HIS B 314 PRO B 315 LEU B 471 SITE 2 AC8 8 GLU B 472 ASP B 474 ARG B 476 TRP B 497 SITE 1 AC9 7 VAL B 357 TYR B 361 ASN B 393 TYR B 432 SITE 2 AC9 7 LYS B 434 PHE B 516 SER B 520 SITE 1 AD1 11 ARG B 351 ALA B 356 ALA B 363 LEU B 448 SITE 2 AD1 11 ILE B 451 ALA B 452 TYR B 454 GLU B 481 SITE 3 AD1 11 GLY B 482 PRO B 484 HOH B 793 CRYST1 74.973 95.287 115.361 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013338 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010495 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008668 0.00000